Senior Health Update & Blog - Page 3 of 37

The drug fasudil may help reverse some of the effects of schizophrenia

Schizophrenia is a mental disorder that impacts behavior and perceptions of reality. Researchers are still working to understand brain changes present in schizophrenia and the best approaches to treatment. Data from a recent study found...

Cardiovascular health: Irregular sleeping habits may increase atherosclerosis risk

A new study finds a link between irregular sleeping patterns and subclinical symptoms of atherosclerosis in older people. Atherosclerosis-related diseases are the leading cause of death in the United States. The study underscores the importance...

Faster cognitive decline linked with food insufficiency in new study

A new study has found that food insufficiency is associated with more rapid cognitive decline. Researchers analyzed data for thousands of individuals regarding their level of food insecurity, cognitive health, and whether they benefitted from...

Is Parkinson’s an autoimmune disease? More evidence emerges

Researchers in Germany have found further evidence to support the idea that Parkinson’s could be an autoimmune disease. By Catharine Paddock, Ph.D. on July 23, 2018 Fact checked by Jasmin Collier read full article

Dementia only causes about 41% of cognitive decline: Study identifies other predictors

Cognitive decline naturally occurs as we age, with a common belief that dementia is the cause in most cases. Researchers at the Ohio State University say there are more factors causing cognitive decline than we...

Hypertension: 2 blood pressure drugs equally effective in large trial

Hypertension, or high blood pressure, affects more than one billion people worldwide and almost half of all adults in the United States. The condition can increase the risk of heart, brain, kidney, and other diseases....

Late-stage melanoma: Experimental drug combo puts 50% of patients into remission

Researchers tested the efficacy of a drug combination for treating stage IV melanoma. They found that 71% of patients responded to the drug combination, and 50% had complete remission. The drug combination is now entering...

High doses of statins may impact bone health, mouse study finds

A new study examined the effects that higher doses of statins, drugs that can lower cholesterol, have on the body in terms of bone health. The researchers used mice in the study who were fed...

Lecanemab: Why a new Alzheimer’s drug has drawn praise and some concern

With the number of Alzheimer’s cases increasing, the medical community needs treatments for this disease now more than ever. One experimental drug, lecanemab, has been hailed by some experts as the treatment we have all...

Parkinson’s disease: Zinc may enhance a protein’s protective role

Experts believe several factors contribute to the development of Parkinson’s disease. Some studies suggest one factor may be the formation of Lewy bodies in the brain, created by clusters of a protein called alpha-synuclein. Previous...